NASDAQ: EDIT       Editas Medicine
Last Price Today's Change   Day's Range   Trading Volume
31.25   -0.355 (1.12%)  30.85 - 31.65  35,219


Avg Volume (4 weeks):892,905
4 Weeks Range:27.01 - 35.06
4 Weeks Price Volatility (%):
52 Weeks Range:14.01 - 39.96
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Editas Medicine Inc is a US-based genome editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company operates its business in a single segment of Developing and commercializing genome editing technology.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1991  3741  509  3161 

Top 10 Active Counters
 LK 1.38+1.38 
 AMTD 39.97-0.85 
 PGNX 4.10-0.425 
 XOG 0.271-0.062 
 NOK 3.355-0.695 
 PINS 67.895+18.645 
 NIO 28.967+1.456 
 F 8.215+0.515 
 TMUSR 0.121+0.031 
 GE 7.725+0.305